Patents by Inventor Lloyd Old

Lloyd Old has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
    Patent number: 6774226
    Abstract: The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: August 10, 2004
    Assignees: Ludwig Institute for Cancer Research, Cornell Research Foundation, Inc.
    Inventors: Dirk Jager, Elizabeth Stockert, Matthew Scanlan, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-tseng Chen
  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
    Publication number: 20040126398
    Abstract: The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ranifications of this observation are also a part of this invention.
    Type: Application
    Filed: February 24, 2003
    Publication date: July 1, 2004
    Inventors: Dirk Jager, Elisabeth Stockert, Matthew Scanlan, Alexander Knuth, Lloyd Old, Ali Gure, Yao-Tseng Chen, Elke Jager
  • Method for determining protein component in a biological sample
    Publication number: 20030040027
    Abstract: Plasmon resonance is used to determine presence of immunoactive molecules, such as antibodies, against therapeutic agents administered to subjects. The determination can be used as an indicia of therapeutic efficacy lack thereof, or problems resulting from the agent.
    Type: Application
    Filed: August 16, 2002
    Publication date: February 27, 2003
    Inventors: Gerd Ritter, Leonard S. Cohen, Lloyd Old, Sydney Welt
  • Isolated cancer associated antigens NY-MEL 1 and NY-MEL 3, peptides based thereon, and their uses
    Publication number: 20030017547
    Abstract: The invention relates to isolated, cancer associated antigens, nucleic acid molecules, and various uses thereof.
    Type: Application
    Filed: May 21, 2002
    Publication date: January 23, 2003
    Inventors: Dirk Jager, Elizabeth Stockert, Matthew Scanlan, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-Tseng Chen
  • Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
    Patent number: 6448073
    Abstract: The invention relates to isolated, cancer associated antigens, nucleic acid molecules, and various uses thereof.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: September 10, 2002
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Dirk Jager, Elizabeth Stockert, Matthew Scanlan, Ali Gure, Elke Jager, Alexander Knuth, Lloyd Old, Yao-tseng Chen
  • Monoclonal antibodies to melanoma cells
    Patent number: 5009995
    Abstract: This invention relates to monoclonal antibodies recognizing the gp130 antigen of human cells. Monoclonal antibodies which recognize distinct determinants on this antigen and methods of detecting the determinants by immunoassay with the monoclonal antibodies which recognize them are disclosed. The monoclonal antibodies are useful in the detection of the gp130 antigen and human cells including melanoma which contain this antigen.
    Type: Grant
    Filed: March 11, 1988
    Date of Patent: April 23, 1991
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Anthony Albino, Kenneth Lloyd, Hisami Ikeda, Lloyd Old
  • Monoclonal antibodies against melanocytes
    Patent number: 4806628
    Abstract: Monoclonal antibodies were discovered which recognize differentiation antigens on melanocytes and melanoma cells at various stages of differentiation. A system of classification based on these antigens is proposed and their use in the diagnosis and treatment of melanoma is given.
    Type: Grant
    Filed: March 17, 1986
    Date of Patent: February 21, 1989
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Anthony Albino, J. Gregory Cairncross, Magdalena Eisinger, Alan N. Houghton, Lloyd Old